Pricing

Lantheus Holdings Inc (LNTH)

followers ·
Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
CEO:
Mary A. Heino
Employees:
700
331 TREBLE COVE ROAD, NORTH BILLERICA, MA, 01862
978 671-8001
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates disease burden of prostate cancer by quantifying the hotspots on bone scans.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available